AI Adoption in Clinical Trials

Results from our poll conducted at CTTC in London

Pistoia Alliance conducted a poll at the Clinical Trials Technology Congress (CTTC) in London to understand the impact of AI and real-world data on clinical trials.  Our data shows that while AI is beginning to deliver value in clinical development, trust and regulatory uncertainty are the biggest barriers to AI adoption in clinical trials, cited by half of respondents (50%). The poll also examined the value of real-world data, including social media listening, in shaping clinical development operations.